Albumin-conjugated MMAE prodrugs exhibited a 7.5-fold higher releaseefficiency under the same irradiation dose compared to nonalbumin-conjugatedprodrugs, significantly inhibiting tumor growth in mice (Figure g,h, RABiT-MMAE andRad-Act-NP). This evidence concerns the gene ALB and neoplasm.